Quantcast

Latest Lymphocytic Leukemia Stories

2015-05-22 08:27:19

Would Become First EMA-approved Therapy for Patients in Europe SUNNYVALE, Calif., May 22, 2015 /PRNewswire/ -- Pharmacyclics, Inc.

2015-05-13 16:33:22

IMBRUVICA Combination Data in Chronic Lymphocytic Leukemia to be Featured in Official ASCO Press Program SUNNYVALE, Calif., May 13, 2015 /PRNewswire/ -- Pharmacyclics, Inc.

2015-05-01 08:28:40

SUNNYVALE, Calif., May 1, 2015 /PRNewswire/ -- Pharmacyclics, Inc.

2015-04-21 12:35:13

SEATTLE, April 21, 2015 /PRNewswire/ -- Seattle Children's announced today that 20 of 22 patients treated thus far in a clinical trial using genetically reprogrammed T cells to treat relapsed

2015-04-20 08:32:19

Oral Presentation at the American Association of Cancer Research Annual Meeting PHILADELPHIA, April 20, 2015 /PRNewswire/ -- Pharmacyclics, Inc.

2015-03-30 12:31:35

WHITE PLAINS, N.Y., March 30, 2015 /PRNewswire-USNewswire/ -- A promising University of Michigan research project focused on developing new treatments for patients with a rare and lethal subtype


Word of the Day
begunk
  • To befool; deceive; balk; jilt.
  • An illusion; a trick; a cheat.
The word 'begunk' may come from a nasalised variant of Scots begeck ("to deceive, disappoint"), equivalent to be- +‎ geck.